Cancer Family
Malignant Nervous System Neoplasm
CI-CAN-00000246Explore in graph →
953 active trials7 approved drugs131 evidence items
- NCIt
- C4788
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000246Explore in graph →
Clinical trials
3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (495)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00636805 | Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab | terminated | Phase 2 | 63 | Duke UniversityOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT00979017 | Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme | completed | Phase 2 | 41 | Katy PetersOTHER | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00657267 |
| Dose-Intense Temozolomide in Recurrent Glioblastoma |
| completed |
| Phase 2 |
| 58 |
| Patrick Y. Wen, MDOTHER |
| 1 |
| Mar 14, 2014 |
| clinicaltrials |
| NCT00611325 | Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma | completed | Phase 2 | 56 | Duke UniversityOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00337883 | A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme) | completed | Phase 2 | 110 | Genentech, Inc.INDUSTRY | 0 | Mar 4, 2014 | clinicaltrials |
| NCT00017368 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | completed | Phase 2 | 42 | Children's Oncology GroupNETWORK | 2 | Feb 13, 2014 | clinicaltrials |
| NCT00084695 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | unknown | Phase 2 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00575887 | Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma | completed | Phase 2 | 25 | Marmara UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00002803 | Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma | completed | Phase 2 | 44 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01400958 | Nuvigil or Placebo in Newly Diagnosed Malignant Glioma | terminated | Phase 2 | 6 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00921167 | A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas | completed | Phase 2 | 32 | Clinical Research Center for Solid Tumor, KoreaOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00431561 | Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma | completed | Phase 2 | 141 | Isarna Therapeutics GmbHINDUSTRY | 6 | Dec 3, 2013 | clinicaltrials |
| NCT01640509 | Synchrotron Radiation to the Treatment of Intracranial Tumors(ESRF) | unknown | Phase 1 / Phase 2 | 50 | University Hospital, GrenobleOTHER | 1 | Nov 11, 2013 | clinicaltrials |
| NCT00003292 | S9624 Ifosfamide in Treating Patients With Meningeal Tumors | terminated | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 4 | Nov 8, 2013 | clinicaltrials |
| NCT00004110 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00919737 | Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme | completed | Phase 1 / Phase 2 | 24 | NobelpharmaINDUSTRY | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01818713 | Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases | unknown | Phase 2 | 6 | The Netherlands Cancer InstituteOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT00053326 | Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00070525 | Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00036712 | Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation | unknown | Phase 2 | 80 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00281905 | Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | unknown | Phase 2 | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00416559 | Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only | unknown | Phase 2 | 140 | Children's Cancer and Leukaemia GroupOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00003743 | Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation | unknown | Phase 2 | 25 | St. Anna KinderkrebsforschungOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00025649 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | completed | Phase 2 | — | European Infant Neuroblastoma Study Group - 1999OTHER | 11 | Sep 17, 2013 | clinicaltrials |
| NCT00276679 | Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma | completed | Phase 2 | — | Children's Cancer and Leukaemia GroupOTHER | 3 | Sep 17, 2013 | clinicaltrials |
| NCT00392340 | Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | unknown | Phase 2 | 63 | Children's Cancer and Leukaemia GroupOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00953121 | Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) | completed | Phase 2 | 104 | Annick DesjardinsOTHER | 1 | Sep 16, 2013 | clinicaltrials |
| NCT00003122 | Surgery in Treating Patients With Neuroblastoma | unknown | Phase 2 | 210 | Societe Internationale d'Oncologie PediatriqueOTHER | 8 | Aug 26, 2013 | clinicaltrials |
| NCT01205334 | Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme(COGLI) | terminated | Phase 1 / Phase 2 | 2 | Baylor College of MedicineOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00003203 | Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors | completed | Phase 2 | 168 | Children's Oncology GroupNETWORK | 3 | Aug 23, 2013 | clinicaltrials |
| NCT00305656 | AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Aug 22, 2013 | clinicaltrials |
| NCT00612430 | Ph II Bevacizumab + Etoposide for Pts w Recurrent MG | completed | Phase 2 | 59 | Duke UniversityOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00024193 | Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma | unknown | Phase 2 | — | Children's Cancer and Leukaemia GroupOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00672243 | Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme | completed | Phase 2 | 32 | Duke UniversityOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00017225 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | completed | Phase 2 | — | German Society for Pediatric Oncology and Hematology GPOH gGmbHOTHER | 3 | Aug 2, 2013 | clinicaltrials |
| NCT00039494 | Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors | completed | Phase 2 | 171 | National Cancer Institute (NCI)NIH | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00016328 | CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme | completed | Phase 2 | 33 | National Cancer Institute (NCI)NIH | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00014170 | Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 2 | 92 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00613028 | Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan | completed | Phase 2 | 23 | Duke UniversityOTHER | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00003505 | Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00389766 | High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma | withdrawn | Phase 2 | 0 | Children's Cancer and Leukaemia GroupOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT00002634 | Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00717197 | Study of Capecitabine to Treat Recurrent High Grade Gliomas | completed | Phase 2 | 30 | University of FloridaOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00002560 | Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma | completed | Phase 2 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00002675 | Chemotherapy in Treating Patients With Retinoblastoma | completed | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT01095926 | Pharmacokinetic Study of Doxorubicin in Children With Cancer(Doxo) | completed | Phase 2 | 101 | University Hospital MuensterOTHER | 4 | Jun 28, 2013 | clinicaltrials |
| NCT00003737 | Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 1, 2014source: clinicaltrials